{
  "docId": "019dd923-5fec-763b-95cd-961b6879cda6",
  "docSlug": "njj0K6xhOdjDOAwq28MP",
  "documentTitle": "See the 39-slide presentation that Moderna used to win over investors on its way to becoming the hottest company in biotech",
  "authorId": "Pitchdecks",
  "authorName": "Moderna",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.29,
  "pageNumber": 32,
  "pageCount": 39,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide compares monotherapy (anti-PDL1, IL-12 mRNA) against combination therapy at different doses, showing a clear synergistic effect.",
  "elementsJson": [
    "headline_text",
    "line_chart",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95cd-961b6879cda6/32",
  "deckHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.92,
        "x": 0.06,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Tumor growth curves for monotherapy and combination therapy groups",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28445009-ec53-426e-9659-b9fe06b811a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.6,
        "y": 0.92
      },
      "kind": "image",
      "text": "AstraZeneca Moderna",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e897d79d-29fe-4d63-9c10-edb82d783101",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.06,
        "y": 0.65
      },
      "kind": "list",
      "text": "MC38-resistant model (colon cancer); mRNA encoded for IL-12; 5 µg mRNA dose near MTD; Formulated with N1GL; Single iTu dose mRNA; Multiple IP dose Ab regimen; Vertical dashed lines indicate dose days",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0f6bb11-4ac0-49d8-a0e8-8e258eb90fbc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Complete Response (CR): 11 CR",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-d521-73bf-9bb7-5ff6f7710cb3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.55,
        "x": 0.06,
        "y": 0.11
      },
      "kind": "title",
      "text": "Synergistic efficacy with IL-12 mRNA and anti-PDL1 antibody therapy in mice",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f6732bb5-c2eb-4839-9943-50828027fcae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.06,
        "y": 0.05
      },
      "kind": "title",
      "text": "Immuno-Oncology iTu – mRNA-2905",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a35ca2a6-c6cd-48b1-866c-ba558f4b3a8b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "evidence-matrix",
      "slug": null,
      "matchId": "7526cf44-619f-40dd-8523-cd594e7dbb39",
      "evidence": "Comparison of monotherapy vs combination therapy across dose levels",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}